Antibodies to combat viral infections: development strategies and progress

Monoclonal antibodies (mAbs) are appealing as potential therapeutics and prophylactics for viral infections owing to characteristics such as their high specificity and their ability to enhance immune responses. Furthermore, antibody engineering can be used to strengthen effector function and prolong...

Descripción completa

Detalles Bibliográficos
Autores principales: Pantaleo, Giuseppe, Correia, Bruno, Fenwick, Craig, Joo, Victor S., Perez, Laurent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207876/
https://www.ncbi.nlm.nih.gov/pubmed/35725925
http://dx.doi.org/10.1038/s41573-022-00495-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207876/
https://www.ncbi.nlm.nih.gov/pubmed/35725925
http://dx.doi.org/10.1038/s41573-022-00495-3

Ejemplares similares